60 Degrees Pharmaceuticals reports 5.45% Lind Global stake

60 Degrees Pharmaceuticals, Inc. received a Schedule 13G from Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton reporting a beneficial ownership position in its common stock.

Rhea-AI Filing Summary

60 Degrees Pharmaceuticals, Inc. received a Schedule 13G from Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton reporting a beneficial ownership position in its common stock.

Each reporting person has sole voting and dispositive power over 191,571 shares, representing 5.45% of the common stock. Their holdings consist of 191,571 shares of common stock and 191,571 Series A Warrants plus 191,571 Series B Warrants. Due to conversion limitations in the warrants, their beneficial ownership is limited to an aggregate of 191,571 shares. The warrants include a provision that restricts conversion if it would cause the holder to beneficially own more than 4.99% of the company.

Key Figures

Beneficially owned shares: 191,571 shares Percent of class: 5.45% Series A Warrants held: 191,571 +3 more

6 metrics

Beneficially owned shares 191,571 shares Shares of common stock beneficially owned by each reporting person

Percent of class 5.45% Percentage of 60 Degrees Pharmaceuticals common stock class held by each reporting person

Series A Warrants held 191,571 Number of Series A Warrants held by each reporting person

Series B Warrants held 191,571 Number of Series B Warrants held by each reporting person

Beneficial ownership cap 4.99% Warrant conversion limited so holder cannot exceed 4.99% beneficial ownership

Sole voting power 191,571 shares Shares over which each reporting person has sole voting power

Key Terms

beneficial ownership, sole dispositive power, Series A Warrants, Series B Warrants, +1 more

5 terms

beneficial ownership financial

"the reporting person's beneficial ownership has been limited to 191,571 shares in the aggregate"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

sole dispositive power financial

"Sole Dispositive Power 191,571.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Series A Warrants financial

"191,571 warrants to purchase shares of common stock (the "Series A Warrants")"

Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.

Series B Warrants financial

"191,571 warrants to purchase shares of common stock (the "Series B Warrants""

Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.

conversion limitations financial

"however, due to the conversion limitations on the Warrants, the reporting person's beneficial ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in SXTP does Lind Global Fund III report on this Schedule 13G?

Lind Global Fund III reports beneficial ownership of 191,571 shares of 60 Degrees Pharmaceuticals common stock, representing 5.45% of the outstanding class, with sole voting and sole dispositive power over those shares according to the filing.

How are Lind Global Fund III’s holdings in SXTP structured?

The reporting person’s interest consists of 191,571 common shares, 191,571 Series A Warrants and 191,571 Series B Warrants. Because of warrant conversion limits, beneficial ownership is capped at 191,571 shares in the aggregate under the disclosure.

What conversion limitation applies to the SXTP warrants held by the reporting persons?

The warrants contain a provision that prevents conversions if doing so would cause the holder to beneficially own more than 4.99% of 60 Degrees Pharmaceuticals. This “conversion limitation” effectively caps the number of shares they can count as beneficially owned.

Who are the reporting persons on the SXTP Schedule 13G and how are they related?

The reporting persons are Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton. Lind Global Partners III LLC is the general partner of Lind Global Fund III LP, and Jeff Easton is the managing member of Lind Global Partners III LLC.

What voting and dispositive powers over SXTP shares are reported by Lind Global entities and Jeff Easton?

Each reporting person discloses sole voting power over 191,571 shares and sole dispositive power over 191,571 shares, with no shared voting or dispositive power, as set out in the ownership section of the Schedule 13G.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 05:12 PM Accepted by SEC EDGAR 08/05/2026 - 05:11 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

60 DEGREES PHARMACEUTICALS, INC.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

83006G500

(CUSIP Number)

07/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

Lind Global Fund III LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 191,571.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 191,571.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

191,571.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.45 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of (i) 191,571 shares of common stock, (ii) 191,571 warrants to purchase shares of common stock (the "Series A Warrants"), and (iii) 191,571 warrants to purchase shares of common stock (the "Series B Warrants," together with the Series A Warrants, the "Warrants"); however, due to the conversion limitations on the Warrants, the reporting person's beneficial ownership has been limited to 191,571 shares in the aggregate. (2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 4.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

Lind Global Partners III LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 191,571.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 191,571.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

191,571.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.45 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of (i) 191,571 shares of common stock, (ii) 191,571 Series A Warrants, and (iii) 191,571 Series B Warrants; however, due to the conversion limitations on the Warrants, the reporting person's beneficial ownership has been limited to 191,571 shares in the aggregate. (2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 4.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 83006G500

1

Names of Reporting Persons

EASTON JEFF

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 191,571.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 191,571.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

191,571.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.45 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: 1) The reporting person's ownership consists of (i) 191,571 shares of common stock, (ii) 191,571 Series A Warrants, and (iii) 191,571 Series B Warrants; however, due to the conversion limitations on the Warrants, the reporting person's beneficial ownership has been limited to 191,571 shares in the aggregate. 2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 4.99% of the Company.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: 60 DEGREES PHARMACEUTICALS, INC.
(b)	Address of issuer's principal executive offices: 1025 Connecticut Avenue, NW Suite 1000, Washington D.C., District of Columbia, 20036
Item 2.
(a)	Name of person filing: This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): Lind Global Fund III LP, a Delaware limited partnership; Lind Global Partners III LLC, a Delaware limited liability company; and Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners III LLC, the general partner of Lind Global Fund III LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP. Jeff Easton, the managing member of Lind Global Partners III LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP.
(b)	Address or principal business office or, if none, residence: The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022
(c)	Citizenship: See Row 4 of cover page for each Reporting Person.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 83006G500
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page for each Reporting Person.
(b)	Percent of class: See Row 11 of cover page for each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lind Global Fund III LP

Signature:	Lind Global Partners III LLC, its General Partner
Name/Title:	Jeff Easton, Managing Member
Date:	08/05/2026

Lind Global Partners III LLC

Signature:	Lind Global Partners III LLC
Name/Title:	Jeff Easton, Managing Member
Date:	08/05/2026

EASTON JEFF

Signature:	Jeff Easton
Name/Title:	Jeff Easton, Managing Member
Date:	08/05/2026

Exhibit Information

Exhibit 99.1 - Joint Filing Agreement